---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001375"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:38:49.468455+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences Enters Consulting Agreement with ABK Labs for Digital Asset Strategy

## Summary
- Artelo signed a 4-year consulting agreement with ABK Labs for strategic advisory on digital asset strategy, business development, and investor relations.
- Company agreed to issue warrants to purchase 55,000 shares at $10.20 per share, subject to board approval and performance milestones.
- Warrants vest in tranches based on continued service and achievement of market capitalization thresholds, with acceleration provisions.
- ABK Labs will advise on digital asset allocation, partnerships, financial modeling, and communication of Artelo's digital asset strategy.

## SEC filing metadata
- accession: 0001640334-25-001375
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001375/0001640334-25-001375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001375/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001375
- JSON: https://secwatch.observer/filing/0001640334-25-001375.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001375.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.